These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24330103)

  • 1. Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease.
    Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Lee R; Tunhasiriwet A; Aryurachai K
    Eur J Haematol; 2014 Apr; 92(4):346-53. PubMed ID: 24330103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular hemolysis, vascular endothelial cell activation and thrombophilia in splenectomized patients with hemoglobin E/β-thalassemia disease.
    Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Aryurachai K
    Acta Haematol; 2014; 132(1):100-7. PubMed ID: 24525823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
    El-Beshlawy A; Youssry I; El-Saidi S; El Accaoui R; Mansi Y; Makhlouf A; Taher A
    Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.
    Atichartakarn V; Likittanasombat K; Chuncharunee S; Chandanamattha P; Worapongpaiboon S; Angchaisuksiri P; Aryurachai K
    Int J Hematol; 2003 Aug; 78(2):139-45. PubMed ID: 12953808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical indicators for pulmonary arterial hypertension in thalassemia.
    Chueamuangphan N; Wongtheptien W; Nawarawong W; Sukornthasarn A; Chuncharunee S; Tawichasri C; Patumanond J
    J Med Assoc Thai; 2012 Jan; 95(1):16-21. PubMed ID: 22379736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension risk in patients with hemoglobin h disease: low incidence and absence of correlation with splenectomy.
    Yin XL; Zhang XH; Wu ZK; Zhao DH; Zhou YL; Yu YH; Liu TN; Fang SP; Zhou TH; Wang L; Huang J
    Acta Haematol; 2013; 130(3):153-9. PubMed ID: 23711936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and beta-thalassemia/Hb E with cholelithiasis.
    Tankanitlert J; Morales NP; Fucharoen P; Fucharoen S; Chantharaksri U
    Eur J Haematol; 2008 Apr; 80(4):351-5. PubMed ID: 18081723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.
    Uaprasert N; Satitthummanid S; Akkawat B; Sutcharitchan P; Rojnuckarin P
    Thromb Res; 2019 Feb; 174():104-112. PubMed ID: 30584959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pulmonary hypertension in patients with β thalassemia intermedia.
    Karimi M; Musallam KM; Cappellini MD; Daar S; El-Beshlawy A; Belhoul K; Saned MS; Temraz S; Koussa S; Taher AT
    Eur J Intern Med; 2011 Dec; 22(6):607-10. PubMed ID: 22075289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study.
    Derchi G; Galanello R; Bina P; Cappellini MD; Piga A; Lai ME; Quarta A; Casu G; Perrotta S; Pinto V; Musallam KM; Forni GL;
    Circulation; 2014 Jan; 129(3):338-45. PubMed ID: 24081970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients.
    Banyatsuppasin W; Butthep P; Atichartakarn V; Thakkinstian A; Archararit N; Pattanapanyasat K; Chuncharunee S
    Am J Hematol; 2011 Jan; 86(1):89-92. PubMed ID: 21064134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension.
    van Beers EJ; van Eck-Smit BL; Mac Gillavry MR; van Tuijn CF; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Biemond BJ; Schnog JJ;
    Chest; 2008 Mar; 133(3):646-52. PubMed ID: 18198257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients.
    Li EK; Tam LS
    J Rheumatol; 1999 Sep; 26(9):1923-9. PubMed ID: 10493670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in spontaneous platelet aggregation in beta-thalassemia/hemoglobin E disease: a consequence of splenectomy.
    Opartkiattikul N; Funahara Y; Fucharoen S; Talalak P
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():36-41. PubMed ID: 1298991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in dialysis patients.
    Oygar DD; Zekican G
    Ren Fail; 2012; 34(7):840-4. PubMed ID: 22680782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
    Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
    Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin levels and red blood cell indices in mid-gestational fetuses with beta-thalassemia/HbE, beta-thalassemia trait or Hb E trait and normal fetuses.
    Srisupundit K; Wanapirak C; Sirichotiyakul S; Tongprasert F; Leuwan S; Traisrisilp K; Tongsong T
    Prenat Diagn; 2013 Dec; 33(13):1238-41. PubMed ID: 24030808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in beta-thalassemia.
    Aessopos A; Farmakis D
    Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective analysis for prevalence of complications in Thai nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H disease).
    Ekwattanakit S; Siritanaratkul N; Viprakasit V
    Am J Hematol; 2018 May; 93(5):623-629. PubMed ID: 29359464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.